Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation

NCT02232425 is registered in ClinicalTrials.gov with Ixchelsis Limited as lead sponsor.

NCT NCT02232425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02232425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An 8-Week, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of IX-01 on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Lifelong Premature Ejaculation
Lead sponsor
Ixchelsis Limited
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
October 31, 2015
Enrollment
88 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

premature ejaculation